It was also found that mice with conditional deletion of prdm1 in CD8+ T cells controlled LCMV infection more effectively than WT mice (Shin et al., 2009), and that anti-CD19 CAR-T cells lacking Blimp-1 have improved in vivo tumor control (Yoshikawa et al., 2022). This evidence concerns the gene PRDM1 and neoplasm.